Building on the successful market entry of AMSilk’s fiber applications, Christian will focus on strengthening the Company’s commercial performance and scaling its proprietary silk protein technology and advanced precision fermentation capabilities across additional applications and markets. Drawing on his experience in scaling businesses and driving profitable growth, he will work to translate AMSilk’s strong technological foundation into a profitable and sustainable business, with a particular focus on the Consumer Care Solutions division.

Christian Wichert brings more than 25 years of international leadership experience. Throughout his career, he has built and led organizations across different industries and markets, with a strong focus on organizational development, execution, and performance. Most recently, he served as Chief Executive Officer of Evolva AG, a publicly listed Swiss biotechnology company, where he gained extensive capital markets experience and headed the company through a period of strategic transformation, including its sale to Danstar Ferment AG/Lallemand Group. Earlier in his career, he held international leadership roles across the specialty chemicals, consumer packaged goods, MedTech, and industrial biotech, thereby gaining wide-ranging experience in several key application areas which are strategically important for AMSilk’s future growth.

Christian Wichert, newly appointed Chief Executive Officer, said: “AMSilk is a true pioneer in its field, and I am honored to join as Chief Executive Officer at such an important stage in the Company’s development. What particularly impressed me is the combination of a unique technology with significant market potential and a highly committed and purpose-driven team. This creates a compelling foundation for further growth and the development of new applications. My priority will be to build on these strengths and support AMSilk in realizing its full potential across its key markets.”

Ulrich Scherbel, who successfully led AMSilk from technology development to commercial market entry, will remain with the Company as Managing Director and assume responsibility as Chief Operating Officer Premium Filaments. He commented: “Christian’s appointment marks an important milestone and AMSilk’s next phase of growth. I am proud of what we have achieved, transforming AMSilk by securing strategic partnerships with 21^st.BIO, Evonik, and Ajinomoto, and bringing the first commercially available products based on AMSilk’s biotech silk protein yarns to market. I look forward to continuing to develop our Premium Filament business as a key strategic growth pillar and value driver for AMSilk.”

Dr. Wolfgang Colberg, Chairman of the Board at AMSilk, commented; “AMSilk’s core focus is now on accelerating scale-up and strengthening commercial execution. Christian brings a strong track record in leading international businesses, driving performance and building the organizational structures required for sustainable growth. His appointment reflects our ambition to further strengthen AMSilk’s market position and prepare the Company for the next stage of its evolution. We would like to thank Ulrich Scherbel for his excellent stewardship during his time as CEO and are thankful to retain his experience and leadership within our newly structured management team.”